Valneva IPO Presentation Deck

Valneva's Management Team Thomas Lingelbach President & Chief Executive Officer CEO of Intercell, Managing Director for Novartis Vaccines & Diagnostics Germany, VP Global Industrial Operations at Chiron Vaccines; 30 years in the vaccine industry. intercell SMART VACCINES CHIRON U NOVARTIS VACCINES Valneva - Roadshow Presentation Franck Grimaud President & Chief Business Officer CEO of Vivalis, formerly responsible for Groupe Grimaud's development in Asia; 25 years in corporate business development and life sciences. GROUPE GRIMAUD Prendre soin de la vie Vivalis Frédéric Jacotot General Counsel & Corporate Secretary VP Legal & IP and General Counsel of Valneva, former Division Counsel at Abbott; 30 years in the pharmaceutical industry. Abbott Juan Carlos Jaramillo, MD Chief Medical Officer Senior international positions including GSK, Celsion, Grünenthal and Daiichi Sankyo; 20 years in life sciences. gsk Celsion Corporation GRÜNENTHAL Daiichi-Sankyo David Lawrence Acting Chief Financial Officer V CFO of Acambis plc, VP Finance at Chiron Vaccines, GSK, non- executive and strategic advisory experience; 30 years in vaccines and life sciences. gsk CHIRON Acambis The sure of vaccines. Toder April 2021 4

View entire presentation